- Release Date: 02/12/20 09:08
- Summary: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
- Price Sensitive: Yes
- Download Document 116.21KB
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
- There are more pages in this discussion • 572 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
-0.030(2.82%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.03 | $6.196M | 5.945M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 164784 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 144640 | 30 |
View Market Depth
| Last trade - 14.34pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.04 |
Change
-0.030 ( 2.71 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.08 | $1.03 | 1515630 | ||
| Last updated 14.45pm 06/06/2024 ? | |||||
| MSB (ASX) Chart |